146 related articles for article (PubMed ID: 12528036)
1. Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU.
Frank U; Chojnacki T; Dettenkofer M; Daschner FD
Intensive Care Med; 2003 Jan; 29(1):139. PubMed ID: 12528036
[No Abstract] [Full Text] [Related]
2. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Maki DG; Stolz SM; Wheeler S; Mermel LA
Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
Veenstra DL; Saint S; Sullivan SD
JAMA; 1999 Aug; 282(6):554-60. PubMed ID: 10450717
[TBL] [Abstract][Full Text] [Related]
5. Are antiseptic-coated central venous catheters effective in a real-world setting?
Borschel DM; Chenoweth CE; Kaufman SR; Hyde KV; VanDerElzen KA; Raghunathan TE; Collins CD; Saint S
Am J Infect Control; 2006 Aug; 34(6):388-93. PubMed ID: 16877109
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
Schwebel C; Lucet JC; Vesin A; Arrault X; Calvino-Gunther S; Bouadma L; Timsit JF
Crit Care Med; 2012 Jan; 40(1):11-7. PubMed ID: 21926570
[TBL] [Abstract][Full Text] [Related]
7. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization.
Walz JM; Avelar RL; Longtine KJ; Carter KL; Mermel LA; Heard SO;
Crit Care Med; 2010 Nov; 38(11):2095-102. PubMed ID: 20711070
[TBL] [Abstract][Full Text] [Related]
8. The quantity and duration of the antimicrobial efficacy of a chlorhexidine and silversulfadiazine impregnated catheter.
Schierholz JM; Beuth J; Pulverer G
J Hosp Infect; 1999 Jun; 42(2):163-5. PubMed ID: 10389069
[No Abstract] [Full Text] [Related]
9. Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater.
Crnich CJ; Maki DG
Clin Infect Dis; 2004 May; 38(9):1287-92. PubMed ID: 15127342
[TBL] [Abstract][Full Text] [Related]
10. A pioneer approach to preventing central venous catheter infections.
Carlson RW; Patterson T
Crit Care Med; 2010 Nov; 38(11):2255-7. PubMed ID: 20959753
[No Abstract] [Full Text] [Related]
11. Catheter-related bloodstream infection.
Goede MR; Coopersmith CM
Surg Clin North Am; 2009 Apr; 89(2):463-74, ix. PubMed ID: 19281894
[TBL] [Abstract][Full Text] [Related]
12. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and prevention of catheter-related infections.
Timsit JF
Curr Opin Crit Care; 2007 Oct; 13(5):563-71. PubMed ID: 17762237
[TBL] [Abstract][Full Text] [Related]
14. [Anaphylactic shock associated with a central venous catheter impregnated with chlorhexidine and silver sulfadiazine].
Terazawa E; Nagase K; Masue T; Niwa Y; Fukao I; Shimonaka H; Yokoi T; Kondoh N; Dohi S
Masui; 1998 May; 47(5):556-61. PubMed ID: 9621664
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
16. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis.
Rosenthal VD; Guzman S; Migone O; Crnich CJ
Am J Infect Control; 2003 Dec; 31(8):475-80. PubMed ID: 14647110
[TBL] [Abstract][Full Text] [Related]
17. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections.
Tennenberg S; Lieser M; McCurdy B; Boomer G; Howington E; Newman C; Wolf I
Arch Surg; 1997 Dec; 132(12):1348-51. PubMed ID: 9403542
[TBL] [Abstract][Full Text] [Related]
19. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
20. Central venous catheters and bloodstream infection.
Schierholz J; Lefering R; Neugebauer E; Beuth J; König DP; Pulverer G
JAMA; 2000 Jan; 283(4):477-8; author reply 478-9. PubMed ID: 10659869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
